בשל "הגנת זכויות יוצרים" מובא להלן קישור לתקציר המאמר. לקריאתו בטקסט מלא, אנא פנה/י לספרייה הרפואית הזמינה לך.
The opioid epidemic has generated interest in optimizing opioid prescribing after common surgeries.
Recent studies have shown a broad range of analgesic prescription patterns following endoscopic sinus surgery (ESS).
We compare the efficacy of different analgesic regimens after ESS.
This multi-institutional, nonblinded randomized clinical trial was conducted at 6 tertiary centers across the US and Canada and included participants who underwent ESS for acute or chronic rhinosinusitis.
The study was conducted from March 2019 to March 2020, and the data were analyzed in November to December 2020.
All participants received acetaminophen, 650 mg, as the first-line analgesic. From there, patients were randomized to either oxycodone rescue (oxycodone, 5 mg, as second-line therapy) or ibuprofen rescue (ibuprofen, 600 mg, as second-line therapy, with oxycodone, 5 mg, reserved for breakthrough pain).